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Background: Low plasma level of high-density lipoprotein cholesterol (HDL) is known to be arisk factor of coronary artery disease. However, there 
have been limited data whether the impact of low HDL on the angiographic and clinical outcomes of the acute myocardial infarction (AMI) patients 
(pts) undergoing percutaneous coronary intervention (PCI).
Methods: A total of 799 AMI pts underwent PCI with DESs were enrolled. The pts were divided into two groups: Low HDL group (HDL-C<40mg/dl in 
male and HDL-C <50mg/dl in female, n= 408) and control group (n=391). Mid-term angiographic outcomes and major clinical outcomes up to 2 
years were compared between the two groups.
Results: Baseline characteristics were similar between the two groups except Low HDL group had more elderly, female, diabetes, triglyceride, and 
less cholesterol than control group. At 6-months, angiographic outcomes were similar between the two groups. However, Low HDL group had higher 
incidence of in-hospital total death and cardiac death than those of control group. Further, Low HDL group showed higher incidence of total death, 
cardiac death and TLR-MACEs up to 2 years than those of control group (Table). Multivariate analysis showed that Low HDL was an independent 
predictor of cardiac death up to 2 years (Adjusted OR 2.107, CI 1.01-4.39, p=0.047).
Conclusions: Low HDL level was associated with higher incidence of short term and long term adverse clinical events. Particularly, Low HDL level 
was an independent predictor of cardiac death at 2 years.
